DEPOSITION OF C3B AND IC3B ONTO PARTICULATE ACTIVATORS OF THE HUMAN-COMPLEMENT SYSTEM - QUANTITATION WITH MONOCLONAL-ANTIBODIES TO HUMAN C-3

被引:97
|
作者
NEWMAN, SL [1 ]
MIKUS, LK [1 ]
机构
[1] UNIV N CAROLINA, DEPT MICROBIOL IMMUNOL, CHAPEL HILL, NC 27514 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1985年 / 161卷 / 06期
关键词
D O I
10.1084/jem.161.6.1414
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1414 / 1431
页数:18
相关论文
共 50 条
  • [41] CONTROL OF HUMAN CLASSICAL COMPLEMENT PATHWAY C-3 CONVERTASE - INHIBITION OF C-3 CLEAVAGE BY C5 OR CELL-BOUND C3B
    STRUNK, RC
    GICLAS, PC
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1011 - 1011
  • [42] HUMAN-COMPLEMENT RECEPTORS FOR C3B (CR-1) AND C3D (CR-2)
    FEARON, DT
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1985, 85 (01) : S53 - S57
  • [43] MONOCLONAL-ANTIBODIES TO HUMAN-COMPLEMENT COMPONENT-C4
    YMAN, IM
    FOLKERSEN, J
    STIGBRAND, T
    SJOQUIST, J
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1984, 20 (02) : 185 - 185
  • [44] Impaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus
    Goldblatt, Fiona
    Yuste, Jose
    Isenberg, David A.
    Rahman, Anisur
    Brown, Jeremy
    RHEUMATOLOGY, 2009, 48 (12) : 1498 - 1501
  • [45] REGULATION OF THE CLASSICAL PATHWAY CONVERTASE OF HUMAN-COMPLEMENT BY THE C3B RECEPTOR FROM HUMAN-ERYTHROCYTES
    GIGLI, I
    FEARON, DT
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 1172 - 1172
  • [46] 2 DIFFERENT COMPLEMENT RECEPTORS ON HUMAN LYMPHOCYTES - ONE SPECIFIC FOR C3B AND ONE SPECIFIC FOR C3B INACTIVATOR-CLEAVED C3B
    ROSS, GD
    POLLEY, MJ
    RABELLINO, EM
    GREY, HM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 138 (04): : 798 - 811
  • [47] ENHANCING EFFECT OF AUTOLOGOUS HUMAN-ERYTHROCYTES ON GENERATION OF C-3 CLEAVAGE PRODUCTS BEYOND IC3B
    JEPSEN, HH
    TEISNER, B
    FOLKERSEN, J
    SVEHAG, SE
    COMPLEMENT, 1988, 5 (03): : 120 - 129
  • [48] Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC)
    Ueki, T
    Mizuno, M
    Uesu, T
    Kiso, T
    Nasu, J
    Inaba, T
    Kihara, Y
    Matsuoka, Y
    Okada, H
    Fujita, T
    Tsuji, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (02): : 286 - 292
  • [49] DETECTION OF NATIVE HUMAN-COMPLEMENT COMPONENTS C-3 AND C5 AND THEIR PRIMARY ACTIVATION PEPTIDES C3A AND C5A (ANAPHYLATOXIC PEPTIDES) BY ELISAS WITH MONOCLONAL-ANTIBODIES
    KLOS, A
    IHRIG, V
    MESSNER, M
    GRABBE, J
    BITTERSUERMANN, D
    JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 111 (02) : 241 - 252
  • [50] STRUCTURAL CHARACTERIZATION OF THE C3B INACTIVATOR (C3BINA) MEDIATED CLEAVAGE OF HUMAN C-3
    DAVIS, AE
    HARRISON, RA
    MOLECULAR IMMUNOLOGY, 1982, 19 (11) : 1366 - 1366